1. The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
   Nour el Imane Issam Salah et al, 2023, Frontiers in Immunology CrossRef
2. The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer
   Xiaoxue Xie et al, 2020, Frontiers in Immunology CrossRef
3. Comparison of PD-L1 and VISTA expression status in primary and recurrent/refractory tissue after (chemo)radiotherapy in head and neck cancer
   Görkem Yazıcı Şener et al, 2023, Strahlentherapie und Onkologie CrossRef
4. MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues
   Tony Yao et al, 2022, Cancer Immunology, Immunotherapy CrossRef
5. Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis
   Xi-Yang Tang et al, 2021, Frontiers in Oncology CrossRef
6. Inhibition of Tumoral VISTA to Overcome TKI Resistance via Downregulation of the AKT/mTOR and JAK2/STAT5 Pathways in Chronic Myeloid Leukemia
   Kexin Ai et al, 2024, Biomolecules & Therapeutics CrossRef
7. Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer
   Zelin Hou et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
8. VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer
   Xi Cao et al, 2021, Frontiers in Oncology CrossRef
9. Alternative Checkpoints as Targets for Immunotherapy
   Ayush Pant et al, 2020, Current Oncology Reports CrossRef
10. The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
    Negar Hosseinkhani et al, 2021, Frontiers in Immunology CrossRef
11. Prognostic value of VISTA in solid tumours: a systematic review and meta-analysis
    Xin-Lin He et al, 2020, Scientific Reports CrossRef
12. Nanoparticles targeting immune checkpoint protein VISTA induce potent antitumor immunity
    Taylor J Moon et al, 2024, Journal for ImmunoTherapy of Cancer CrossRef
13. Structural Basis of VSIG3: The Ligand for VISTA
    Xiaoxue Xie et al, 2021, Frontiers in Immunology CrossRef
14. Expression of VISTA on tumor-infiltrating immune cells correlated with short intravesical recurrence in non-muscle-invasive bladder cancer
    Won Ik Seo et al, 2021, Cancer Immunology, Immunotherapy CrossRef
15. VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
    Ran Ren et al, 2023, Open Medicine CrossRef